0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Mobile health as a viable strategy to enhance stroke risk factor control: A systematic review and meta-analysis

      , , , , ,
      Journal of the Neurological Sciences
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          <div class="section"> <a class="named-anchor" id="S1"> <!-- named anchor --> </a> <h5 class="section-title" id="d9448472e167">Background</h5> <p id="P2">With the rapid growth worldwide in cell-phone use, Internet connectivity, and digital health technology, mobile health (mHealth) technology may offer a promising approach to bridge evidence-treatment gaps in stroke prevention. We aimed to evaluate the effectiveness of mHealth for stroke risk factor control through a systematic review and meta-analysis. </p> </div><div class="section"> <a class="named-anchor" id="S2"> <!-- named anchor --> </a> <h5 class="section-title" id="d9448472e172">Methods</h5> <p id="P3">We searched PubMed from January 1, 2000 to May 17, 2016 using the following keywords: mobile health, mHealth, short message, cellular phone, mobile phone, stroke prevention and control, diabetes mellitus, hypertension, hyperlipidemia and smoking cessation. We performed a meta-analysis of all eligible randomized control clinical trials that assessed a sustained (at least 6 months) effect of mHealth. </p> </div><div class="section"> <a class="named-anchor" id="S3"> <!-- named anchor --> </a> <h5 class="section-title" id="d9448472e177">Results</h5> <p id="P4">Of 78 articles identified, 13 met eligibility criteria (6 for glycemic control and 7 for smoking cessation) and were included for the final meta-analysis. There were no eligible studies for dyslipidemia or hypertension. mHealth resulted in greater Hemoglobin A1c reduction at 6 months (6 studies; 663 subjects; SMD: −0.44; 95% CI: [−0.82, −0.06], P=0.02; Mean difference of decrease in HbA1c: −0.39%; 95% CI: [−0.74, −0.04], P=0.03). mHealth also lead to relatively higher smoking abstinence rates at 6 months (7 studies; 9,514 subjects; OR: 1.54; 95% CI: [1.24, 1.90], P&lt;0.0001). </p> </div><div class="section"> <a class="named-anchor" id="S4"> <!-- named anchor --> </a> <h5 class="section-title" id="d9448472e182">Conclusions</h5> <p id="P5">Our meta-analysis supports that use of mHealth improves glycemic control and smoking abstinence rates. </p> </div>

          Related collections

          Author and article information

          Journal
          Journal of the Neurological Sciences
          Journal of the Neurological Sciences
          Elsevier BV
          0022510X
          July 2017
          July 2017
          : 378
          : 140-145
          Article
          10.1016/j.jns.2017.04.050
          5503473
          28566151
          61108a35-5bda-4b1f-88cc-d916ef6adea2
          © 2017

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article